From "directed differentiation" to "neuronal induction": modeling neuropsychiatric disease
Seok-Man Ho1, Aaron Topol1, Kristen J Brennand1
1Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, NY, USA.
Biomarker Insights
|June 6, 2015
Summary
Human induced pluripotent stem cell (hiPSC) technology enables the generation of human neurons for studying neurological diseases. This approach overcomes limitations of postmortem tissues and animal models in understanding psychiatric disorder mechanisms.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Aberrant neuronal function underlies neurological and psychiatric disorders.
- Human postmortem samples are limited and animal models fail to capture polygenic origins.
- Somatic cell reprogramming offers a novel method for generating human neurons for disease research.
Purpose of the Study:
- To review the development of human induced pluripotent stem cell (hiPSC) technology.
- To introduce methods for generating neurons from hiPSCs for disease modeling.
- To discuss the applications and limitations of hiPSC-derived neurons in psychiatric disorder research.
Main Methods:
- Review of human induced pluripotent stem cell (hiPSC) technology.
- Description of directed differentiation and neuronal induction techniques.
- Analysis of in vitro studies utilizing hiPSC-derived neurons.
Main Results:
- hiPSC technology provides a nearly limitless supply of human neurons.
- Directed differentiation and neuronal induction are key methods for neuron generation.
- These in vitro models offer insights into disease mechanisms but have limitations.
Conclusions:
- hiPSC-derived neurons are a powerful tool for studying neurological and psychiatric diseases.
- This technology overcomes limitations of traditional research methods.
- Further research is needed to address the limitations of in vitro modeling.
